| Up
2005P-0501:
Revise FDA's guidance entitled labeling for combined oral contraeceptives
so that the labels of combined oral contraceptives have warnings
relating to the risk of thromboembolic disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 12/20/2005
|
| 12/20/2005
|
| Private Industry
|
| Hyman, Phelps &
McNamara, P.C
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Rogers C. Thies
|
|
|
|
|
| ACK1
|
| 12/20/2005
|
| 12/20/2005
|
| Federal Government
|
| HFA-305 to Hyman,
Phelps & McNamara, P.C
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
| LET1
|
| 06/16/2006
|
| 06/16/2006
|
| Private Industry
|
| FDA/CDER to Hyman,
Phelps & McNamara, P.C
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
| |
Top | Up
Page last updated
July 24, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
